Multiple cytochrome P-450 subfamilies are co-induced with P-glycoprotein by both phenothiazine and 2-acetylaminofluorene in rats

Cancer Letters

Volumn 138, Issue 1-2, 1999, Pages 73-79

  Tateishi, Tomonori ^a   Nakura, Hironori ^a   Asoh, Masako ^a   Watanabe, Minoru ^a   Tanaka, Masami ^a   Kumai, Toshio ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 Acetylaminofluorene; Cytochrome P 450 family; P glycoprotein; Phenothiazine; Sprague Dawley rat

Indexed keywords

CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; GLYCOPROTEIN P; N (2 FLUORENYL)ACETAMIDE; PENTOXYRESORUFIN DEALKYLASE; PHENOTHIAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

2-ACETYLAMINOFLUORENE; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; LIVER; MALE; P-GLYCOPROTEIN; PHENOTHIAZINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033606093     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00374-7     Document Type: Article

References (21)

1. Bellamy W.T., Dalton W.S., Dorr R.T. The clinical relevance of multidrug resistance. Cancer Invest. 8:1990;547-562.
2. Chin K.-V., Pastan I., Gottesman M.M. Function and regulation of the human multidrug resistance gene. Adv. Cancer Res. 60:1993;157-180.
3. Watanabe T., Suzuki H., Sawada Y., Naito M., Tsuruo T., Inaba M., Hanano M., Sugiyama Y. Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. J. Hepatol. 23:1995;440-448.
4. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdrla P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96:1995;1698-1705.
5. Wacher V.J., Wu C.Y., Benet L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P4503A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinogen. 13:1995;129-134.
6. Schuetz E.G., Beck W.T., Schuetz J.D. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:1996;311-318.
7. Guengerich F.P. Human cytochrome P450 enzymes. Oritiz de Montellano P.R. Cytochrome P450. 2nd edn. 1995;473 Plenum Press, New York.
8. Burt R.K., Thorgeirsson S.S. Coincidence of MDR-1 multidrug resistance and cytochrome P450 genes in rat liver by xenobiotics. J. Natl. Cancer Inst. 80:1988;1383-1386.
9. Schuetz E.G., Furuya K.N., Schuetz J.D. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J. Pharmacol. Exp. Ther. 275:1995;1011-1018.
10. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239:1964;2370-2378.
11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
12. Paolini M., Mesirca R., Pozzetti L., Sapone A., Cantelli-Forti G. Molecular non-genetic biomarkers related to fenarimol cocarcinogenesis: organ- and sex-specific CYP induction in rat. Cancer Lett. 101:1996;171-178.
13. Schenkman J.B., Remmer H., Estabrook R.W. Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol. Pharmacol. 3:1967;113-123.
14. Niwa T., Kaneko H., Naritomi Y., Togawa A., Shiraga T., Iwasaki K., Tozuka Z., Hata T. Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog and monkey. Xenobiotics. 25:1995;1041-1049.
15. Cribb A.E., Spielberg S.P., Griffin G.P. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab. Dispos. 23:1995;406-414.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
17. Guengerich F.P., Wang P., Davidson N.K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and human using immunochemical staining coupled with sodium dodecylsulfate-polyacrylamide gel electrophoresis. Biochemistry. 21:1982;1698-1706.
18. Weisburger E.K. Mechanistic considerations in chemical carcinogenesis. Regul. Toxicol. Pharm. 12:1990;41-52.
19. Ioannides C., Cheung Y.-L., Wilson J., Lewis D.F.V., Gray T.J.B. The mutagenicity and interactions of 2- and 4-(acetylamino)fluorene with cytochrome P450 and the aromatic hydrocarbon receptor may explain the difference in their carcinogenic potency. Chem. Res. Toxicol. 6:1993;535-541.
20. Kawajiri K., Hayashi S.-I. The CYP1 family. Ioannides C. Cytochrome P450: Metabolic and Toxicological Aspects. 1995;77 CRC Press, Boca Raton, FL.
21. Oritz de Montellano P.R., Costa A.K. Dissociation of cytochrome P-450 inactivation and induction. Arch. Biochem. Biophys. 251:1986;514-524.